PD-1-Inhibitoren: Immuntherapie gegen Krebs
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Frontiers | Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
IJMS | Free Full-Text | Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
PD-L1
Immune Checkpoint Inhibitors - NCI
Onkolgische Pflege: Immunonkologische Therapien | MSD Care
PD-L1-Inhibitoren | Gelbe Liste
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review | Cancer Cell International | Full Text
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations | Journal for ImmunoTherapy of Cancer
Wann wirkt eine Immun-Checkpoint-Blockade bei metastasiertem Melanom? - einBLICK - Online-Magazin der Universität Würzburg
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Clinical trial compares interval dosing of two immune checkpoint inhibitors | Center for Cancer Research
Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules - ScienceDirect
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
Frontiers | Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice
PD1 Antibody Selection Tool | Bio X Cell
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
